Aviva’s Taylor Morrison TMHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$330K Sell
5,664
-4,310
-43% -$269K ﹤0.01% 816
2025
Q4
$587K Buy
9,974
+1,618
+19% +$98.9K ﹤0.01% 700
2025
Q3
$552K Sell
8,356
-733
-8% -$48.2K ﹤0.01% 693
2025
Q2
$558K Buy
+9,089
New +$528K ﹤0.01% 687
2023
Q4
Sell
-13,315
Closed -$567K 1020
2023
Q3
$567K Sell
13,315
-18,245
-58% -$858K ﹤0.01% 853
2023
Q2
$1.54M Sell
31,560
-8,304
-21% -$358K 0.01% 691
2023
Q1
$1.53M Buy
39,864
+5,656
+17% +$199K 0.01% 718
2022
Q4
$1.04M Sell
34,208
-29,888
-47% -$833K 0.01% 792
2022
Q3
$1.5M Sell
64,096
-16,514
-20% -$429K 0.01% 800
2022
Q2
$1.88M Buy
+80,610
New +$2.13M 0.01% 865

Other funds holding TMHC

Aviva's TMHC Position: Q1 2026 in Review

Aviva reduced its Taylor Morrison (TMHC) stake by 43% in Q1 2026, selling an estimated $269K and leaving 5,664 shares worth $330K. The position accounts for ﹤0.01% of the portfolio, ranked #816.

Aviva first reported a position in TMHC in Q2 2022 and has held it in 10 quarters since. The position peaked at $1.88M in Q2 2022. 449 funds tracked by Wall St. Rank hold TMHC as of Q1 2026.

  • Aviva held 5,664 shares of Taylor Morrison worth $330K as of Q1 2026.
  • Aviva sold 4,310 Taylor Morrison shares in Q1 2026, an estimated $269K.
  • Taylor Morrison made up ﹤0.01% of Aviva's portfolio in Q1 2026, its #816 holding.
  • Aviva first reported a position in Taylor Morrison in Q2 2022 and has held it in 10 quarters since.
  • Aviva's Taylor Morrison position peaked at $1.88M in Q2 2022.
  • 449 funds tracked by Wall St. Rank held Taylor Morrison as of Q1 2026.

Based on Aviva's 13F filing for Q1 2026, filed 14 May 2026.